Corrigendum to “Optimizing treatment in homozygous familial hypercholesterolemia: Monocentric observational clinical study on efficacy and safety of evinacumab and lomitapide combination” [J Clin Lipidol 20 (2026) 1086-1096]
Corrigendum to “Optimizing treatment in homozygous familial hypercholesterolemia: Monocentric observational clinical study on efficacy and safety of evinacumab and lomitapide combination” [J Clin Lipidol 20 (2026) 1086-1096]. // Journal of Clinical Lipidology. – URL: https://www.sciencedirect.com/science/article/pii/S1933287426004496?dgcid=rss_sd_all
Corrigendum to “Optimizing treatment in homozygous familial hypercholesterolemia: Monocentric observational clinical study on efficacy and safety of evinacumab and lomitapide combination” [J Clin Lipidol 20 (2026) 1086-1096]. Journal of Clinical Lipidology. https://www.sciencedirect.com/science/article/pii/S1933287426004496?dgcid=rss_sd_all
“Corrigendum to “Optimizing treatment in homozygous familial hypercholesterolemia: Monocentric observational clinical study on efficacy and safety of evinacumab and lomitapide combination” [J Clin Lipidol 20 (2026) 1086-1096].” Journal of Clinical Lipidology.
@article{article52883,
title = {Corrigendum to “Optimizing treatment in homozygous familial hypercholesterolemia: Monocentric observational clinical study on efficacy and safety of evinacumab and lomitapide combination” [J Clin Lipidol 20 (2026) 1086-1096]},
journal = {Journal of Clinical Lipidology},
url = {https://www.sciencedirect.com/science/article/pii/S1933287426004496?dgcid=rss_sd_all}
}